SCHEMBL4804942

SCHEMBL4804942

Oc1ccc(-c2nc3cc(F)ccc3s2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 0.68
SULT1A1 P50225 1/20 0.68
MAPT P10636 3/20 0.61
KDM4E B2RXH2 2/20 0.61
NPC1 O15118 2/20 0.61
ALDH1A1 P00352 2/20 0.61
GAA P10253 2/20 0.61
RAB9A P51151 2/20 0.61
LMNA P02545 1/20 0.61
GLA P06280 1/20 0.61
AHR P35869 1/20 0.59
HDAC3 O15379 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
TP53 P04637 1/20 0.55
THRB P10828 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MEN1 O00255 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13806234 0.90 APP (0.77) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL4804599 0.87 APP (0.82) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL4809936 0.84 AHR (0.60) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL5691159 0.84 APP (0.77) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL10706363 0.84 APP (0.68) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL27897630 0.83 AHR (0.58) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL4797697 0.83 NFKB1 (0.68) APPSULT1A1KDM4ENPC1RAB9A
SCHEMBL13254486 0.83 MAPT (0.70) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL10710841 0.81 AHR (0.57) APPSULT1A1MAPTKDM4ENPC1
SCHEMBL27897607 0.81 AHR (0.57) APPSULT1A1MAPTKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384966-B2 2-arylbenzothiazole derivatives PHARMINXO LIMITED (GB) 2008-06-10 US disclosed
US-20060063816-A1 2-Arylbenzothiazole derivatives STEVENS MALCOLM F G 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063816-A1 2-Arylbenzothiazole derivatives CX3CR1, HCN2, CYBB APP 1876/4885SULT1A1 285/4885MAPT 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.